APA
Young E., Noerenberg D., Mansouri L., Ljungström V., Frick M., Sutton L., Blakemore S. J., Galan-Sousa J., Plevova K., Baliakas P., Rossi D., Clifford R., Roos-Weil D., Navrkalova V., Dörken B., Schmitt C. A., Smedby K. E., Juliusson G., Giacopelli B., Blachly J. S., Belessi C., Panagiotidis P., Chiorazzi N., Davi F., Langerak A. W., Oscier D., Schuh A., Gaidano G., Ghia P., Xu W., Fan L., Bernard O. A., Nguyen-Khac F., Rassenti L., Li J., Kipps T. J., Stamatopoulos K., Pospisilova S., Zenz T., Oakes C. C., Strefford J. C., Rosenquist R. & Damm F. (20170926). EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. : Leukemia.
Chicago
Young E, Noerenberg D, Mansouri L, Ljungström V, Frick M, Sutton L-A, Blakemore S J, Galan-Sousa J, Plevova K, Baliakas P, Rossi D, Clifford R, Roos-Weil D, Navrkalova V, Dörken B, Schmitt C A, Smedby K E, Juliusson G, Giacopelli B, Blachly J S, Belessi C, Panagiotidis P, Chiorazzi N, Davi F, Langerak A W, Oscier D, Schuh A, Gaidano G, Ghia P, Xu W, Fan L, Bernard O A, Nguyen-Khac F, Rassenti L, Li J, Kipps T J, Stamatopoulos K, Pospisilova S, Zenz T, Oakes C C, Strefford J C, Rosenquist R and Damm F. 20170926. EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. : Leukemia.
Harvard
Young E., Noerenberg D., Mansouri L., Ljungström V., Frick M., Sutton L., Blakemore S. J., Galan-Sousa J., Plevova K., Baliakas P., Rossi D., Clifford R., Roos-Weil D., Navrkalova V., Dörken B., Schmitt C. A., Smedby K. E., Juliusson G., Giacopelli B., Blachly J. S., Belessi C., Panagiotidis P., Chiorazzi N., Davi F., Langerak A. W., Oscier D., Schuh A., Gaidano G., Ghia P., Xu W., Fan L., Bernard O. A., Nguyen-Khac F., Rassenti L., Li J., Kipps T. J., Stamatopoulos K., Pospisilova S., Zenz T., Oakes C. C., Strefford J. C., Rosenquist R. and Damm F. (20170926). EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. : Leukemia.
MLA
Young E, Noerenberg D, Mansouri L, Ljungström V, Frick M, Sutton L-A, Blakemore S J, Galan-Sousa J, Plevova K, Baliakas P, Rossi D, Clifford R, Roos-Weil D, Navrkalova V, Dörken B, Schmitt C A, Smedby K E, Juliusson G, Giacopelli B, Blachly J S, Belessi C, Panagiotidis P, Chiorazzi N, Davi F, Langerak A W, Oscier D, Schuh A, Gaidano G, Ghia P, Xu W, Fan L, Bernard O A, Nguyen-Khac F, Rassenti L, Li J, Kipps T J, Stamatopoulos K, Pospisilova S, Zenz T, Oakes C C, Strefford J C, Rosenquist R and Damm F. EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. : Leukemia. 20170926.